WiseTech Global Ltd (ASX: WTC) shares are continuing their impressive run on Tuesday.

At the time of writing, the ASX 200 tech stock is up 10.43% to $39.06. By comparison, the S&P/ASX 200 Index (ASX: XJO) is relatively flat at 8,833 points.

WiseTech shares have now climbed 15% over the past week, although they remain down 43% since the start of 2026.

After such a heavy fall this year, the latest gain suggests investors are responding to signs of progress.

So, what did WiseTech announce?

Richard White hands over the chair role

According to the release, Raelene Murphy has been appointed Independent Chair with immediate effect.

Murphy only joined the WiseTech board at the start of this year, but has already been moved into a bigger role. She became lead Independent Director in May and is now taking over the chair position.

However, White isn’t stepping away from the company. He will remain on the board as an Executive Director and continue as Chief Innovation Officer.

This means he will still be involved in the parts of WiseTech that investors probably care about most, including product, technology, and growth.

White said recent personal media attention had become an unnecessary distraction from the strength of the business. He also repeated that he denies the recent allegations reported in the media.

Board renewal continues

In addition, WiseTech advised that it isn’t finished with the board changes just yet.

The company said it is still searching for another independent non-Executive Director.

Since March 2025, Chris Charlton, Sandra Hook, Rob Castaneda, and Murphy have all been appointed as independent non-Executive Directors.

Once the next appointment is made, WiseTech will have a total of 5 Independent Directors on its board.

That should help answer some of the governance concerns that have followed the company over the past year.

WiseTech also pointed to Zubin Appoo’s appointment as CEO in July 2025 as part of its wider succession planning.

The board commented:

Appoo has demonstrated strong leadership since taking on the CEO role, and said it is comfortable with the progress of its executive succession plan.

The business is still growing

Away from the board headlines, WiseTech is still a major global software business.

The company provides software for the logistics, global trade, and supply chain industries. It serves more than 22,000 logistics companies and other industry participants across 193 countries.

And its latest half-year result also showed why investors haven’t completely given up on the stock.

In 1H26, revenue increased 76% to US$672 million, helped by e2open and growth in CargoWise. EBITDA rose 31% to US$252.1 million, although statutory net profit fell 36% to US$68.1 million.

Despite the mixed results, WiseTech is a growing business.

Keep in mind, the underlying business has not changed. If anything, investors now have a better reason to focus on the growth still coming through.

The post WiseTech shares surge 10% as Richard White steps back from chair role appeared first on The Motley Fool Australia.

More reading

• Are WiseTech shares ripe for a rebound?
• How to tell if an ASX share is cheap or a value trap
• Here are the top 10 ASX 200 shares today
• Down 35%+, should you buy Zip and WiseTech shares?
• Can WiseTech shares double from here? Analysts are betting yes

Motley Fool contributor Aaron Teboneras has no position in any of the stocks mentioned. The Motley Fool Australia’s parent company Motley Fool Holdings Inc. has positions in and has recommended WiseTech Global. The Motley Fool Australia has positions in and has recommended WiseTech Global. The Motley Fool has a disclosure policy. This article contains general investment advice only (under AFSL 400691). Authorised by Scott Phillips.

Commonwealth Bank of Australia (ASX: CBA) shares have been fairly resilient so far this year. 

At the time of writing, the ASX bank stock is down slightly, around 0.1%, to $164.57 a piece. For the year to date, however, the shares are still around 2% higher.

CBA shares rocked higher in mid-February after the bank posted an unexpectedly-positive half-year FY26 result. The bank shares were relatively unchanged over the next few months, even in the face of higher inflation and headwinds flowing out from volatility in the Middle East. 

But then, in early-May, CBA shares tanked following a disappointing third-quarter capital update. Investors were spooked by the results at the time and rushed to sell up their shares.

The downturn was short lived though. CBA shares rebounded by the end of May and have stayed relatively consistent since.

It’s clear that CBA shares are still in favour. It’s likely CBA’s safe-haven appeal that continues to appeal to investors. In times of market chaos, investors typically flock to well-known and large-scale stocks.

The problem is that CBA shares have been widely considered overvalued for some time now. CBA is currently trading at a price-to-earnings (P/E) ratio over 26, making it one of the most expensive banking stocks globally. The bumper price tag isn’t supported by the bank’s core strength or earnings either.

Brokers are bearish, with some expecting CBA shares to fall to just $90 a piece over the next 12 months. 

I wouldn’t add CBA shares to my portfolio right now. But the good news is that there are two other ASX bank shares tipped to outperform this year.

I’d buy these ASX bank stocks instead

Analysts expect all the big four banks’ shares, and some mid-tier bank stocks, to decline throughout the second half 2026. 

Data shows that experts think CBA shares carry the most downside risk, with a downside of up to 45% at the time of writing, to $90 each.

But there are two ASX bank shares tipped to travel in the opposite direction this year.

Macquarie Group Ltd (ASX: MQG) is the only S&P/ASX 200 Index (ASX: XJO) bank share that brokers think can keep climbing higher over the next 12 months. Market Index data shows the majority of brokers have a buy rating on Macquarie shares. The $253.54 average target price implies a potential 1% upside, at the time of writing.

And then there is Judo Capital Holdings Ltd (ASX: JDO). Brokers are very bullish on the outlook for Judo Bank shares, with the majority holding a buy rating, according to Market Index data. The average $1.60 target price currently implies an impressive 80% potential upside ahead over the next 12 months.

What sets Macquarie and Judo Bank apart from the rest?

Macquarie is the fifth-largest ASX 200 bank by market capitalisation, and it is incredibly diversified. The bank does more than just banking; it also provides financial, advisory, investment, and fund management services across 34 markets globally. 

That means it has exposure to commodities trading, infrastructure deals, asset management, and capital markets across multiple regions.

Unlike CBA, Macquarie isn’t reliant on lending margins. Its diversity also means that it can remain stable, or even benefit, when markets are going through periods of volatility.

Meanwhile, Judo Bank works differently to its peers. Unlike many other banks in the sector, Judo Bank was built to focus on providing financial services and lending to small and medium enterprises (SMEs). These SMEs have annual turnovers of up to $100 million.

The bank was founded in 2016 and received its banking license in 2019. That means it’s relatively new in comparison to the majors. It was listed on the ASX in 2021.

The bank provides business lending starting at $250,000 and touts itself as providing more flexibility than major banks. It also offers personal term deposit products and home loans.

The post Forget CBA shares, I’d buy these ASX bank stocks instead appeared first on The Motley Fool Australia.

More reading

• How should I invest my money in FY27?
• ASX financials went from the best sector in FY25 to negative growth in FY26. Here’s what changed
• 5 of the best investments on the ASX right now to complement your superannuation
• Judo Bank shares rise despite Morgan Stanley price target cut
• Owned CBA shares for 10 years? Here’s how much money you’ve made

Motley Fool contributor Samantha Menzies has no position in any of the stocks mentioned. The Motley Fool Australia’s parent company Motley Fool Holdings Inc. has positions in and has recommended Macquarie Group. The Motley Fool Australia has recommended Macquarie Group. The Motley Fool has a disclosure policy. This article contains general investment advice only (under AFSL 400691). Authorised by Scott Phillips.

It has been a big few weeks for A2 Milk Company Ltd (ASX: A2M) shares, and Tuesday is bringing more good news for investors.

At the time of writing, the A2 Milk share price is up 3.63% to $7.99.

That means the ASX infant formula stock is now up 54% over the past month.

The latest move comes after the company provided investors with an update on its China supply issues, along with better-than-expected preliminary FY26 results.

So, what changed today?

China supply issues ease

According to the release, A2 Milk said the supply chain problems that hit its China label infant milk formula business have now been mostly sorted out.

The issue came through in the fourth quarter, when the company struggled to keep enough product available.

A2 Milk said this was caused by a few things, including strong demand in the previous quarter, freight challenges, production backlogs, longer release times, and extra customs clearance requirements.

As a result, some customers moved to other brands. Others switched across to A2 Milk’s English label products.

However, things now look to be improving.

The company said product flows to distributors and retailers have materially improved across both its China label and English label products, with stock levels returning to target.

A2 Milk is now trying to win back previous China label users, while also speeding up new customer recruitment with its retail and distribution partners.

Full-year result holds up

The preliminary FY26 result also gave the market something to work with.

A2 Milk expects revenue of approximately NZ$1.97 billion, up more than 12% on FY25. That is slightly ahead of the guidance it gave in April, which was for low to mid-double-digit growth.

The company also expects its EBITDA margin to land at the high end of its 14% to 14.5% guidance range.

Reported net profit after tax (NPAT) is tipped to be slightly higher than FY25, while cash conversion is expected to be around 70%. That’s well ahead of the 50% cash conversion guidance given in April.

There was also decent growth outside the China label business. A2 Milk said English label infant formula, Other Nutritionals, and Liquid Milk all performed well and finished significantly higher than FY25.

Can the rally keep going?

A2 Milk has had plenty go its way over the past few weeks.

Last month, it received approval from China’s State Administration for Market Regulation to transition its China label infant formula product registrations to a2 branded products.

It also declared a NZ$300 million special dividend, equal to 41.362 cents per share. That dividend is due to trade ex-dividend on 8 July.

After a 54% gain in a month, A2 Milk is no longer flying under the radar.

The next major test will be the company’s audited FY26 result and FY27 outlook commentary on 17 August.

The post A2 Milk shares jump again as China worries start to ease appeared first on The Motley Fool Australia.

More reading

• a2 Milk Company posts double digit FY26 revenue growth despite China supply setback
• Why is everyone talking about Mineral Resources, A2 Milk and Pro Medicus shares on Thursday?
• Why A2 Milk, EchoIQ, Lendlease, and Qantas shares are racing higher today
• A2 Milk shares jump amid $300 million special dividend
• A2 Milk declares $300 million special dividend after securing China approval

Motley Fool contributor Aaron Teboneras has no position in any of the stocks mentioned. The Motley Fool Australia’s parent company Motley Fool Holdings Inc. has no position in any of the stocks mentioned. The Motley Fool Australia has no position in any of the stocks mentioned. The Motley Fool has a disclosure policy. This article contains general investment advice only (under AFSL 400691). Authorised by Scott Phillips.